These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The role and significance of sensitivity analyses in enhancing the statistical validity of clinical studies. Baiocchi M; Woo YJ; Chiu P; Goldstone AB J Thorac Cardiovasc Surg; 2022 Feb; 163(2):749-753. PubMed ID: 33229182 [No Abstract] [Full Text] [Related]
9. Statistics in Brief: An Introduction to the Use of Propensity Scores. Inacio MC; Chen Y; Paxton EW; Namba RS; Kurtz SM; Cafri G Clin Orthop Relat Res; 2015 Aug; 473(8):2722-6. PubMed ID: 25773902 [No Abstract] [Full Text] [Related]
10. What Constitutes an Independent Statistical Analysis? Abraham A; Ahn R; Woodbridge A; Madden E; Keyhani S; Korenstein D J Gen Intern Med; 2018 Jun; 33(6):786-788. PubMed ID: 29549498 [No Abstract] [Full Text] [Related]
11. Is Propensity Score Analysis a Valid Surrogate of Randomization for the Avoidance of Allocation Bias? Torres F; Ríos J; Saez-Peñataro J; Pontes C Semin Liver Dis; 2017 Aug; 37(3):275-286. PubMed ID: 28847037 [No Abstract] [Full Text] [Related]
12. Propensity scores: a tool to help quantify treatment effects in observational studies. Patino CM; Ferreira JC J Bras Pneumol; 2017; 43(2):86. PubMed ID: 28538773 [No Abstract] [Full Text] [Related]
13. Lessons from meta-analyses of randomized clinical trials for analysis of distributed networks of observational databases. Bate A; Chuang-Stein C; Roddam A; Jones B Pharm Stat; 2019 Jan; 18(1):65-77. PubMed ID: 30362223 [TBL] [Abstract][Full Text] [Related]
14. Reweighting Randomized Controlled Trial Evidence to Better Reflect Real Life - A Case Study of the Innovative Medicines Initiative. Happich M; Brnabic A; Faries D; Abrams K; Winfree KB; Girvan A; Jonsson P; Johnston J; Belger M; Clin Pharmacol Ther; 2020 Oct; 108(4):817-825. PubMed ID: 32301116 [TBL] [Abstract][Full Text] [Related]
15. An introduction to instrumental variables analysis: part 1. Bennett DA Neuroepidemiology; 2010; 35(3):237-40. PubMed ID: 20861655 [TBL] [Abstract][Full Text] [Related]
16. Statistical power in parallel group point exposure studies with time-to-event outcomes: an empirical comparison of the performance of randomized controlled trials and the inverse probability of treatment weighting (IPTW) approach. Austin PC; Schuster T; Platt RW BMC Med Res Methodol; 2015 Oct; 15():87. PubMed ID: 26472109 [TBL] [Abstract][Full Text] [Related]
17. [Clinical trials: methodological requirements and interpretation]. Windeler J; Lange S Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):394-401. PubMed ID: 19322527 [TBL] [Abstract][Full Text] [Related]
18. Propensity score studies are unlikely to underestimate treatment effects in critical care medicine: a critical reanalysis. Kitsios GD J Clin Epidemiol; 2015 Apr; 68(4):467-9. PubMed ID: 25555686 [No Abstract] [Full Text] [Related]
19. Why do we continue to adopt medical practices based on pathophysiology alone when we should be insisting on clinical trials? Prasad V; Ho N J Clin Epidemiol; 2014 Apr; 67(4):361-3. PubMed ID: 24581292 [No Abstract] [Full Text] [Related]
20. Randomised trials in context: practical problems and social aspects of evidence-based medicine and policy. Pearce W; Raman S; Turner A Trials; 2015 Sep; 16():394. PubMed ID: 26341114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]